Science Explorer Back to mapMap
Institution · University of Alberta

Most cited papers from University of Alberta

What are the most cited papers from University of Alberta?

The most cited paper from University of Alberta is "PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation" (Andrea C. Tricco et al., 2018), with 43,960 citations. Next come "RoB 2: a revised tool for assessing risk of bias in randomised trials" (33,250) and "Geant4—a simulation toolkit" (25,572).

Showing 50 of 60 papers. Every paper with more than 3,120 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation Andrea C. Tricco et al. · Annals of Internal Medicine Open access 3 Sep 2018 43,960
2 RoB 2: a revised tool for assessing risk of bias in randomised trials Jonathan A C Sterne et al. · BMJ Open access 28 Aug 2019 33,250
3 Geant4—a simulation toolkit Stefano Agostinelli et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment Open access127 authors 21 Jun 2003 25,572
4 ModelFinder: fast model selection for accurate phylogenetic estimates Subha Kalyaanamoorthy, Bùi Quang Minh, Thomas K. F. Wong et al. · Nature Methods Open access 8 May 2017 19,804
5 Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination Axel T. Brünger, Paul D. Adams, G. Marius Clore et al. · Acta Crystallographica Section D Biological Crystallography Sep 1998 15,809
6 Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data Hude Quan, Vijaya Sundararajan, Patricia Halfon et al. · Medical Care 13 Oct 2005 10,878
7 Observation of a new particle in the search for the Standard Model Higgs boson with the ATLAS detector at the LHC G. Aad et al. · Physics Letters B Open access2,932 authors 14 Aug 2012 10,856
8 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Christopher J L Murray et al. · The Lancet Open access362 authors Dec 2012 9,055
9 DrugBank 5.0: a major update to the DrugBank database for 2018 David Scott Wishart et al. · Nucleic Acids Research Open access 4 Nov 2017 9,014
10 Apixaban versus Warfarin in Patients with Atrial Fibrillation Christopher B. Granger et al. · New England Journal of Medicine Open access 28 Aug 2011 9,001
11 Mixed-effects modeling with crossed random effects for subjects and items R. Harald Baayen, Douglas J. Davidson, Douglas M. Bates · Journal of Memory and Language Open access 4 Mar 2008 8,736
12 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos et al. · The Lancet Open access358 authors Dec 2012 8,461
13 Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials Mayank Goyal et al. · The Lancet Review 20 Feb 2016 7,859
14 In situ click chemistry generation of cyclooxygenase-2 inhibitors Atul Bhardwaj, Jatinder Paul Kaur, Melinda Wuest et al. · Nature Communications Open access 9 Feb 2017 7,563
15 Management ownership and market valuation Randall K Morck, Andrei Shleifer, Robert W. Vishny · Journal of Financial Economics Open access 1988 7,113
16 Critical Inquiry in a Text-Based Environment: Computer Conferencing in Higher Education D. Randy Garrison, Terry D. Anderson, Walter Archer · The Internet and Higher Education Mar 1999 6,566
17 Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Theo Vos et al. · The Lancet Open access679 authors 7 Jun 2015 6,558
18 Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke Mayank Goyal et al. · New England Journal of Medicine Open access 11 Feb 2015 6,122
19 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
20 Fourth-Generation Evaluation Anne Neufeld, Alan G. Ryan · Canadian Journal of Program Evaluation Sep 1988 5,992
21 Definition and classification of cancer cachexia: an international consensus Kenneth Fearon, Florian Strasser, Stefan D. Anker et al. · The Lancet Oncology 5 Feb 2011 5,828
22 European Position Paper on Rhinosinusitis and Nasal Polyps 2020 W.J. Fokkens et al. · Rhinology Journal Open access148 authors Feb 2020 5,610
23 Erlotinib in Previously Treated Non–Small-Cell Lung Cancer Frances Alice Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine Open access 13 Jul 2005 5,471
24 HUMAN ALTERATION OF THE GLOBAL NITROGEN CYCLE: SOURCES AND CONSEQUENCES Peter M. Vitousek, John D. Aber, Robert Warren Howarth et al. · Ecological Applications Aug 1997 5,459
25 Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma Jedd D. Wolchok et al. · New England Journal of Medicine Open access 11 Sep 2017 5,453
26 Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Laura Evans et al. · Intensive Care Medicine Open access 2 Oct 2021 5,314
27 Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen A.M. James Shapiro, Jonathan R.T. Lakey, Edmond A. Ryan et al. · New England Journal of Medicine Open access 27 Jul 2000 5,299
28 Verification Strategies for Establishing Reliability and Validity in Qualitative Research Janice M. Morse, Michael Barrett, Maria J. Mayan et al. · International Journal of Qualitative Methods Open access Jun 2002 4,986
29 Liposomal drug delivery systems: From concept to clinical applications Theresa M. Allen, Pieter R. Cullis · Advanced Drug Delivery Reviews Review Oct 2012 4,816
30 The basis of anisotropic water diffusion in the nervous system – a technical review Christian Beaulieu · NMR in Biomedicine Nov 2002 4,640
31 Biochar as a sorbent for contaminant management in soil and water: A review Mahtab Ahmad, Anushka Upamali Rajapaksha, Jung Eun Lim et al. · Chemosphere 27 Nov 2013 4,623
32 Drug Delivery Systems: Entering the Mainstream Theresa M. Allen, Pieter R. Cullis · Science 19 Mar 2004 4,545
33 Abiraterone and Increased Survival in Metastatic Prostate Cancer Johann Sebastian De Bono et al. · New England Journal of Medicine Open access 25 May 2011 4,448
34 Global variation in copy number in the human genome Richard Redon et al. · Nature Open access Nov 2006 4,397
35 The ATLAS Experiment at the CERN Large Hadron Collider G. Aad et al. · Journal of Instrumentation Open access2,047 authors 14 Aug 2008 4,271
36 Updated Clinical Classification of Pulmonary Hypertension Gérald Simonneau, Michael Athanassios Gatzoulis, Ian Adatia et al. · Journal of the American College of Cardiology Open access Dec 2013 4,211
37 DrugBank: a comprehensive resource for in silico drug discovery and exploration David Scott Wishart · Nucleic Acids Research Open access 28 Dec 2005 4,078
38 Forecasting Agriculturally Driven Global Environmental Change David Tilman, Joseph Fargione, Brian A. Wolff et al. · Science 13 Apr 2001 4,016
39 The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity Frederick Wolfe, Daniel Joseph Clauw, Mary‐Ann Fitzcharles et al. · Arthritis Care & Research Open access 23 Feb 2010 3,990
40 Sedentary Behavior Research Network (SBRN) – Terminology Consensus Project process and outcome on behalf of SBRN Terminology Consensus Project Participants, Mark Stephen Tremblay, Salomé Aubert et al. · International Journal of Behavioral Nutrition and Physical Activity Open access 31 May 2017 3,898
41 Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Malcolm J. Moore, David B Goldstein, John Turner Hamm et al. · Journal of Clinical Oncology 24 Apr 2007 3,888
42 MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis Jasmine Chong, Othman Soufan, Carin Li et al. · Nucleic Acids Research Open access 13 Apr 2018 3,876
43 PHASTER: a better, faster version of the PHAST phage search tool David Arndt, Jason R. Grant, Ana Marcu et al. · Nucleic Acids Research Open access 3 May 2016 3,841
44 The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection Martín Rudwaleit et al. · Annals of the Rheumatic Diseases Open access 18 Mar 2009 3,707
45 The expanding universe of T-cell subsets: Th1, Th2 and more Tim R. Mosmann, Subash Sad · Immunology Today Mar 1996 3,673
46 Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies Roberto E. Cabeza, Lars H Nyberg · Journal of Cognitive Neuroscience 2000 3,658
47 Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome Gregory G. Schwartz et al. · New England Journal of Medicine Open access 7 Nov 2018 3,654
48 K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer Christos Stelios Karapetis, Shirin Khambata‐Ford, Derek J. Jonker et al. · New England Journal of Medicine 22 Oct 2008 3,629
49 HMDB 4.0: the human metabolome database for 2018 David Scott Wishart et al. · Nucleic Acids Research Open access 23 Oct 2017 3,621
50 Does corporate social responsibility affect the cost of capital? Sadok El Ghoul, Omrane Guedhami, Chuck C.Y. Kwok et al. · Journal of Banking & Finance 11 Feb 2011 3,440

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.